XML 33 R24.htm IDEA: XBRL DOCUMENT v3.8.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Stock-Based Compensation (Details)
3 Months Ended 12 Months Ended
Mar. 31, 2018
USD ($)
Plan
Director
$ / shares
shares
Mar. 31, 2017
USD ($)
shares
Dec. 31, 2016
Mar. 29, 2018
$ / shares
Share-Based Compensation [Abstract]        
Number of stock based compensation plans | Plan 1      
Additional Disclosures [Abstract]        
Proceeds from stock option exercises $ 132,400 [1] $ 258,250    
Closing price of common stock (in dollars per share) | $ / shares       $ 44.34
General and Administrative [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]        
Stock-based compensation expense $ 33,000 $ 33,000    
Stock Options [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of board of directors granted options | Director 2      
Options grant date fair value $ 540,000      
Volatility rate 39.60%      
Risk free rate 2.62%      
Expected term 6 years 3 months      
Stock Options Activity [Roll Forward]        
Outstanding, beginning of period (in shares) | shares 232,000      
Grants (in shares) | shares 30,000 0    
Exercised (in shares) | shares (10,000)      
Forfeitures or expirations (in shares) | shares 0      
Outstanding, end of period (in shares) | shares 252,000      
Exercisable, end of period (in shares) | shares 207,000      
Weighted Average Exercise Price [Roll Forward]        
Outstanding, beginning of period (in dollars per share) | $ / shares $ 21.56      
Grants (in dollars per share) | $ / shares 41.82      
Exercised (in dollars per share) | $ / shares 13.24      
Forfeitures or expirations (in dollars per share) | $ / shares 0      
Outstanding, end of period (in dollars per share) | $ / shares 24.30      
Exercisable, end of period (in dollars per share) | $ / shares $ 20.80      
Weighted Average Remaining Contractual Term [Roll Forward]        
Outstanding 3 years 3 months 14 days   2 years 6 months 7 days  
Grants 0 years      
Exercised 0 years      
Forfeitures or expirations 0 years      
Exercisable 2 years 14 days      
Aggregate Intrinsic Value [Roll Forward]        
Outstanding, beginning of period $ 5,050,990      
Grants 0      
Exercised 0      
Forfeitures or expirations 0      
Outstanding, end of period 5,049,910      
Exercisable, end of period 4,873,810      
Additional Disclosures [Abstract]        
Proceeds from stock option exercises 132,000 $ 258,000    
Unrecognized compensation cost $ 648,000      
Recognized compensation period 3 years 5 months 12 days      
[1] As of January 1, 2018, the Company adopted the requirements of ASC 606 using the modified retrospective adoption method, and as a result, there is a lack of comparability of certain amounts to the prior periods presented. See Note 2 for additional discussion.